Cellectis S.A. and Calyxt, Inc. announced on Thursday the pricing of Calyxt’s initial public offering of 7,000,000 shares of its common stock at the initial public offering price of $8.00 per share.
The company said that the number of shares in the offering represents an increase of 939,394 shares from the 6,060,606 shares previously disclosed, and the initial public offering price represents a decrease from the previously disclosed estimated price range of $15.00 to $18.00 per share.
In addition, Calyxt granted the underwriters for the offering an option to purchase up to 1,050,000 additional shares of Calyxt’s common stock at the initial public offering price less the underwriting discount. The company expects that the offering will close near July 25, 2017.
Calyxt’s shares of common stock have been approved for listing on NASDAQ and are expected to begin trading under the ticker symbol “CLXT” on July 20, 2017.